Notice
Boehringer Ingelheim wishes to thank the following companies who have contributed data to TransCelerate’s DataCelerate platform, which facilitates the sharing of control arm data between participating member companies: [AbbVie, Amgen, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, EMD Serono, GlaxoSmithKline, Genentech, Janssen, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Shionogi, and UCB Biosciences.] Neither TransCelerate Biopharma nor any of the above-referenced companies have contributed to, approved or are in any way responsible for the author’s research results.